Artificial Intelligence (AI) in Precision Medicine Market Predicted to Grow at 32% CAGR During 2025–2029
Get 20% Off Market Intelligence Reports With Code ONLINE20 — Track Global Tariffs, Economic Shifts, and Sector Transformations
What Is the Growth Potential of the Artificial Intelligence (AI) in Precision Medicine Market in the Next Decade?
The artificial intelligence (ai) in precision medicine market size has grown exponentially in recent years. It will grow from $2.33 billion in 2024 to $2.98 billion in 2025 at a compound annual growth rate (CAGR) of 28.0%. The growth in the historic period can be attributed to increasing healthcare data availability, rising chronic disease burden, genomic research advancements, growing emphasis on personalized medicine, and improved computational power.
The artificial intelligence (ai) in precision medicine market size is expected to see exponential growth in the next few years. It will grow to $9.06 billion in 2029 at a compound annual growth rate (CAGR) of 32.0%. The growth in the forecast period can be attributed to the expansion of precision medicine initiatives, rising demand for predictive analytics in healthcare, growth in genomics-based therapies, and increased funding for AI in precision medicine research. Major trends in the forecast period include AI-driven biomarker discovery, increased use of natural language processing in healthcare, enhanced patient stratification through AI, AI-enabled clinical trial optimization, and personalized treatment plans using AI-based decision support systems.
Claim your free report sample now:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12572&type=smp
What Are the Major Drivers Influencing the Artificial Intelligence (AI) in Precision Medicine Market?
The high prevalence of chronic illnesses and respiratory disorders is expected to propel the growth of artificial intelligence in the precision medicine market going forward. Chronic illnesses refer to a medical condition that lasts longer than a year and requires ongoing medical attention, while respiratory disorders are diseases that affect the airways and the lungs. Artificial intelligence in precision medicine helps in diagnosing and predicting the outcomes for people suffering from respiratory diseases based on clinical data and chest imaging. It is used in precision medicine to treat chronic illnesses because it reduces costs and optimizes resource utilization. For instance, in May 2023, the United Nations, a US-based intergovernmental organization, estimated that chronic diseases such as cardiovascular diseases, cancer, diabetes, and respiratory illnesses would account for 86% of the 90 million deaths by 2050. Additionally, in June 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, the death rate associated with chronic conditions increased from 459 deaths per 100,000 people in 2021 to 490 deaths per 100,000 people in 2022. Therefore, the high prevalence of chronic illnesses and respiratory diseases will drive artificial intelligence in the precision medicine market.
Which Segment Holds the Largest Share in the Artificial Intelligence (AI) in Precision Medicine Market?
The artificial intelligence (ai) in precision medicinemarket covered in this report is segmented —
1) By Component: Hardware, Software, Service
2) By Technology: Deep Learning, Querying Method, Natural Language Processing, Context Aware Processing
3) By Therapeutic Application: Oncology, Cardiology, Neurology, Respiratory, Other Therapeutic Applications
Subsegments:
1) By Hardware: AI Processors, High-Performance Computing Systems, Diagnostic Devices
2) By Software: AI Algorithms And Models, Data Analytics Platforms, Genomic Analysis Software, Clinical Decision Support Systems
3) By Service: Consulting Services, Integration Services, Maintenance And Support Services, Training And Education Services
Which Emerging Trends Are Driving the Artificial Intelligence (AI) in Precision Medicine Market?
The development of novel artificial intelligence (AI)-based life sciences solutions is a key trend gaining popularity in artificial intelligence in the precision medicine market. Major companies in the artificial intelligence in the precision medicine market have made various advancements in big data analytics to sustain their position in the market. For instance, in May 2023, Google LLC, a US-based technology corporation, introduced a novel artificial intelligence (AI)-based life sciences solution to speed up drug discovery and precision medicine. The target and lead identification suite, an initiative that boosts the effectiveness of in silico drug development, was developed to help research teams predict protein structure and, more precisely, determine the function of amino acids.
Which Major Companies Are Operating in the Artificial Intelligence (AI) in Precision Medicine Market?
Major companies operating in the artificial intelligence (AI) in precision medicine market include Alphabet Inc., Microsoft Corporation, Intel Corporation, International Business Machines Corporation, AstraZeneca PLC, Sanofi S.A., NVIDIA Corporation, GE HealthCare Technologies Inc., Illumina Inc., QIAGEN N.V., Helix Inc., Sema4 Holdings Corp., SOPHiA GENETICS SA, Insilico Medicine, BenevolentAI Limited, Fabric Genomics Inc., Tempus Technologies Inc., Enlitic Inc., PathAI Inc., Genuity Science Inc., BERG LLC, Perthera Inc., Vuno Inc., CureMetrix Inc., AITIA International Inc., Zephyr AI, Freenome Inc., PetaGene Ltd., Suki AI Inc., BioXcel Therapeutics Inc.
Get the full artificial intelligence (ai) in precision medicine market report here:
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-precision-medicine-global-market-report
Which Region Is Expected to Lead the Artificial Intelligence (AI) in Precision Medicine Market by 2029?
North America was the largest region in the artificial intelligence (AI) in the precision medicine market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in precision medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Americas +1 310–496–7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment